HMGA1a: Sequence-specific RNA-binding factor causing sporadic Alzheimer's disease-linked exon skipping of presenilin-2 pre-mRNA

Genes to Cells

Volumn 12, Issue 10, 2007, Pages 1179-1191

  Manabe, Takayuki ^a,f   Ohe, Kenji ^b,g   Katayama, Taiichi ^a,h   Matsuzaki, Shinsuke ^a   Yanagita, Takeshi ^a   Okuda, Hiroaki ^a   Bando, Yoshio ^c   Imaizumi, Kazunori ^d   Reeves, Raymond ^e   Tohyama, Masaya ^a   Mayeda, Akila ^b,g  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d UNIVERSITY OF MIYAZAKI   (Japan)

^e WASHINGTON STATE UNIVERSITY   (United States)

^f RIKEN KOBE INSTITUTE   (Japan)

^g FUJITA HEALTH UNIVERSITY   (Japan)

^h HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A1A PROTEIN; MESSENGER RNA PRECURSOR; PRESENILIN 2; SMALL NUCLEAR RIBONUCLEOPROTEIN;

5' UNTRANSLATED REGION; ALZHEIMER DISEASE; ARTICLE; BINDING SITE; CELL DEATH; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENDOPLASMIC RETICULUM STRESS; ENZYME REPRESSION; ENZYME SPECIFICITY; EXON; GENE INACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA BINDING; RNA SEQUENCE; RNA SPLICING;

ALTERNATIVE SPLICING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM; EXONS; HMGA1A PROTEIN; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PRESENILIN-2; RNA PRECURSORS; RNA-BINDING PROTEINS;

EID: 34848851109     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2007.01123.x     Document Type: Article

References (38)

1. Bandiera, A., Bonifacio, D., Manfioletti, G., Mantovani, F., Rustighi, A., Zanconati, F., Fusco, A., Di Bonito, L. & Giancotti, V. (1998) Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res. 58, 426-431.
2. Berget, S.M. (1995) Exon recognition in vertebrate splicing. J. Biol. Chem. 270, 2411-2414.
3. Blennow, K., de Leon, M.J. & Zetterberg, H. (2006) Alzheimer's disease. Lancet 368, 387-403.
4. Cáceres, J.F., Stamm, S., Helfman, D.M. & Krainer, A.R. (1994) Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265, 1706-1709.
5. Dominski, Z. & Kole, R. (1991) Selection of splice sites in pre-mRNAs with short internal exons. Mol. Cell. Biol. 11, 6075-6083.
6. Faustino, N.A. & Cooper, T.A. (2003) Pre-mRNA splicing and human disease. Genes Dev. 17, 419-437.
7. Gunderson, S.I., Polycarpou-Schwarz, M. & Mattaj, I.W. (1998) U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase. Mol. Cell 1, 255-264.
8. Hanamura, A., Cáceres, J.F., Mayeda, A., Franza, B.R. Jr. & Krainer, A.R. (1998) Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA 4, 430-444.
9. Hannon, G.J. & Rossi, J.J. (2004) Unlocking the potential of the human genome with RNA interference. Nature 431, 371-378.
10. Higashide, S., Morikawa, K., Okumura, M., Kondo, S., Ogata, M., Murakami, T., Yamashita, A., Kanemoto, S., Manabe, T. & Imaizumi, K. (2004) Identification of regulatory cis -acting elements for alternative splicing of presenilin 2 exon 5 under hypoxic stress conditions. J. Neurochem. 91, 1191-1198.
11. Ignjatovic, T., Yang, J.C., Butler, J., Neuhaus, D. & Nagai, K. (2005) Structural basis of the interaction between P-element somatic inhibitor and U1-70k essential for the alternative splicing of P-element transposase. J. Mol. Biol. 351, 52-65.
12. Jaeger, L.B. & Banks, W.A. (2004) Antisense therapeutics and the treatment of CNS disease. Front. Biosci. 9, 1720-1727.
13. Jurica, M.S. & Moore, M.J. (2003) Pre-mRNA splicing: Awash in a sea of proteins. Mol. Cell 12, 5-14.
14. Katayama, T., Imaizumi, K., Manabe, T., Hitomi, J., Kudo, T. & Tohyama, M. (2004) Induction of neuronal death by ER stress in Alzheimer's disease. J. Chem. Neuroanat. 28, 67-78.
15. Khan, A.U. & Lal, S.K. (2003) Ribozymes: A modern tool in medicine. J. Biomed. Sci. 10, 457-467.
16. Kim, V.N., Kataoka, N. & Dreyfuss, G. (2001) Role of the nonsense-mediated decay factor hUpf3 in the splicing-dependent exon-exon junction complex. Science 293, 1832-1836.
17. Krawczak, M., Reiss, J. & Cooper, D.N. (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences. Hum. Genet. 90, 41-54.
18. Labourier, E., Adams, M.D. & Rio, D.C. (2001) Modulation of P-element pre-mRNA splicing by a direct interaction between PSI and U1 snRNP 70K protein. Mol. Cell 8, 363-373.
19. Manabe, T., Kitayama, T., Ogita, K. & Yoneda, Y. (2000) Differential expression and phosphorylation of particular fos family members by kainate in nuclear and cytosolic fractions of murine hippocampus. Neuroscience 100, 453-463.
20. Manabe, T., Katayama, T., Sato, N., Gomi, F., Hitomi, J., Yanagita, T., Kudo, T., Honda, A., Mori, Y., Matsuzaki, S., Imaizumi, K., Mayeda, A. & Tohyama, M. (2003) Induced HMGA1a expression causes aberrant splicing of Presenilin-2 pre-mRNA in sporadic Alzheimer's disease. Cell Death Differ. 10, 698-708.
21. Manabe, T., Katayama, T., Sato, N., Kudo, T., Matsuzaki, S., Imaizumi, K. & Tohyama, M. (2002) The cytosolic inclusion bodies that consist of splice variants that lack exon 5 of the presenilin-2 gene differ obviously from Hirano bodies observed in the brain from sporadic cases of Alzheimer's disease patients. Neurosci. Lett. 328, 198-200.
22. Matsuzaki, S., Manabe, T., Katayama, T., Nishikawa, A., Yanagita, T., Okuda, H., Yasuda, Y., Miyata, S., Meshitsuka, S. & Tohyama, M. (2004) Metals accelerate production of the aberrant splicing isoform of the presenilin-2. J. Neurochem. 88, 1345-1351.
23. Mayeda, A., Hayase, Y., Inoue, H., Ohtsuka, E. & Ohshima, Y. (1990) Surveying cis -acting sequences of pre-mRNA by adding antisense 2′-O-methyl oligoribonucleotides to a splicing reaction. J. Biochem. 108, 399-405.
24. Mayeda, A. & Krainer, A.R. (1999a) Preparation of HeLa cell nuclear and cytosolic S100 extracts for in vitro splicing. Methods Mol. Biol. 118, 309-314.
25. Mayeda, A. & Krainer, A.R. (1999b) Mammalian in vitro splicing assays. Methods Mol. Biol. 118, 315-321.
26. Nishikawa, A., Manabe, T., Katayama, T., Kudo, T., Matsuzaki, S., Yanagita, T., Okuda, H., Bando, Y. & Tohyama, M. (2004) Novel function of PS2V: Change in conformation of tau proteins. Biochem. Biophys. Res. Commun. 318, 435-438.
27. Reeves, R. (2001) Molecular biology of HMGA proteins: Hubs of nuclear function. Gene 277, 63-81.
28. Reeves, R., Edberg, D.D. & Li, Y. (2001) Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol. Cell. Biol. 21, 575-594.
29. Reeves, R. & Nissen, M.S. (1999) Purification and assays for high mobility group HMG-I(Y) protein function. Methods Enzymol. 304, 155-188.
30. Sakashita, E., Tatsumi, S., Werner, D., Endo, H. & Mayeda, A. (2004) Human RNPS1 and its associated factors: A versatile alternative pre-mRNA splicing regulator in vivo. Mol. Cell. Biol. 24, 1174-1187.
31. Sato, N., Hori, O., Yamaguchi, A., Lambert, J.C., Chartier-Harlin, M.C., Robinson, P.A., Delacourte, A., Schmidt, A.M., Furuyama, T., Imaizumi, K., Tohyama, M. & Takagi, T. (1999) A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue. J. Neurochem. 72, 2498-2505.
32. Sato, N., Imaizumi, K., Manabe, T., et al. (2001) Increased production of β-amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2. J. Biol. Chem. 276, 2108-2114.
33. Schenk, P.M., Baumann, S., Mattes, R. & Steinbiss, H.-H. (1995) Improved high-level expression system for eukaryotic genes in Escherichia coli using T7 RNA polymerase and rare Arg tRNAs. Biotechniques 19, 196-200.
34. Selkoe, D.J. (2001) Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid β-protein. J. Alzheimers Dis. 3, 75-80.
35. Smith, M.J., Sharples, R.A., Evin, G., McLean, C.A., Dean, B., Pavey, G., Fantino, E., Cotton, R.G., Imaizumi, K., Masters, C.L., Cappai, R. & Culvenor, J.G. (2004) Expression of truncated presenilin 2 splice variant in Alzheimer's disease, bipolar disorder, and schizophrenia brain cortex. Brain Res. Mol. Brain Res. 127, 128-135.
36. Weinberg, R.A. & Penman, S. (1968) Small molecular weight monodisperse nuclear RNA. J. Mol. Biol. 38, 289-304.
37. Wood, M.J., Trulzsch, B., Abdelgany, A. & Beeson, D. (2003) Ribozymes and siRNA for the treatment of diseases of the nervous system. Curr. Opin. Mol. Ther. 5, 383-388.
38. Yoneda, Y., Ogita, K., Azuma, Y., Ikeda, M., Tagami, H. & Manabe, T. (1999) N -methyl- d -aspartate signaling to nuclear activator protein-1 through mechanisms different from those for kainate signaling in murine brain. Neuroscience 90, 519-533.